<DOC>
	<DOCNO>NCT01092351</DOCNO>
	<brief_summary>The study aim investigate bacteriological efficacy nitrofurantoin formulation give twice daily seven day treatment adult patient microbiologically confirm uncomplicated urinary tract infection . Additional study objective evaluate clinical efficacy well safety tolerability nitrofurantoin formulation .</brief_summary>
	<brief_title>Efficacy Safety Nitrofurantoin Treatment Uncomplicated Urinary Tract Infections Adults</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Nitrofurantoin</mesh_term>
	<criteria>nonpregnant woman men age 18 year old presence ≥ 2 sign symptom suggestive UTI ( dysuria , urinary frequency , urgency , suprapubic pain ) onset 10 day enrollment asymptomatic patient available positive urine culture pyuria define positive leucocyte esterase ( LE ) test color change two minute collection cleanvoided midstream urine sample culture susceptibility test confirm bacteriuria normal renal function ( define blood creatinine &lt; 1.4 mg/100 ml ) able take oral medication outpatient basis write informed consent enrollment suspicion complicate UTI ( presence fever 38°C , flank pain , know urologic structural abnormality ) prostatitis negative urine dipslide result ( uropathogen &lt; 100000 CFU ( colonyforming unit ) /mL ) presence nitrofurantoin resistant isolate uropathogens mixed culture two isolates symptom UTI within past 4 week evidence predispose factor UTI ( e.g . calculus , stricture , primary renal disease like polycystic renal disease neurogenic bladder ) medical history anaemia , complicate diabetes mellitus , peripheral neuropathy , vitamin B deficiency , renal insufficiency , significant renal , hepatic lung diseases medical history glucose6phosphate dehydrogenase deficiency ( G6PD ) electrolytes disorder pregnant , breastfeed woman use medically accept , effective method birth control history nitrofurantoin hypersensitivity use systemic bacteriological agent within 48 hour enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>urinary tract infection</keyword>
	<keyword>nitrofurantoin</keyword>
</DOC>